Top Tweets for #BioAdaptor
Is #BioAdaptor the answer?
#TCT2025 @crfheart its impact on LDL PCI is worth watching and confirming
Introducing 1st🥇Successful #LithiX (#IntravascularLithotripsy, #IVL) and Bioadaptive #Angioplasty with #DynamX #Bioadaptor System by #Elixir in #NegeriSembilan and Columbia Asia Hospital-#Malaysia🏥 at
KLTan Heart Specialist Clinic- 心脏内科专科
#CRT2025 #JACCINT BIOADAPTOR RCT: Significant sustained clinical benefit at 2 years with DynamX #bioadaptor over a contemporary drug-eluting stent in patients with de novo lesions https://t.co/v3PEeudOeZ #cvCAD
Join us Elixir Series
Advancing PCI standard of care with Bioadaptor
Monday, 20th January 2025 @ 8:00pm to 9:30pm (Saudi Time)
with Renowned Interventional Cardiologists Presenting Complex cases
https://t.co/cEVVca1lAz
#elixir #bioadaptor #cardiologists #interventional
Watch @mirvatalasnag as she offers her perspective on the BIOADAPTOR RCT two-year data and the impact the results could have on her practice and the future of PCI.
#cardiotwitter #Bioadaptor
CE marked. Not for sale in the U.S.
PMN 1993 REV A
📹 Stream an exclusive interview with Dr @mirvatalasnag on the #BioadaptorRCT trial two-year findings! 🔗 https://t.co/T6buhOnHor
Discover how these groundbreaking results could shape the future of #PCI. Explore the study’s design, key findings and implications for clinical practice 🥼🔬
#Cardiology #CardioTwitter
#BreakingNews: #DynamX Sirolimus-Eluting Coronary #Bioadaptor System has been granted @FDA Breakthrough Device Designation for the treatment of symptomatic ischemic heart disease.
https://t.co/uuhNSwAUC3
#cardiotwitter
CE marked. Not for sale in the U.S.
PMN 1891 REV A
“The study suggests “an edge” with Bioadaptor in terms of TLF over the drug-eluting stent.” - @robebyrne.
Read @TCTMD’s article on the #BIOADAPTOR RCT: https://t.co/MAWsvCaOqj
@michaelTCTMD
@mirvatalasnag
#cardiotwitter
CE marked. Not approved in the U.S.
PMN 1887 REV A
ICYMI: At #EuroPCR, we shared late-breaking 2-year data showing #DynamX® Coronary Bioadaptor’s significant clinical advantages vs. DES.
Learn more about the results: https://t.co/Pte3M8xJ7J
CE marked. Not for sale in the U.S.
#Bioadaptor #Medtech #Innovation #CardioTwitter
DynamX Bioadaptor demonstrates significant clinical advantages vs. DES.
Join #ElixirMedical at #EuroPCR 2024 to learn more about #Bioadaptor #DynamX
Sponsored post by @ElixirMed
Thanks to @ElixirMed for their visit at our booth and discuss with our management team.
We are happy and delighted to collaborate for #BIOADAPTOR and #PINNACLE studies over the past few years
#CardioTwitter #Cardiology #EuroPCR 2024
@PCRonline
Technology innovation of the uncaging DynamX and scientific rigor of the Bioadaptor RCT recognized at @PCRonline, thank you Dr Capodanno! @DFCapodanno.
@ElixirMed #bioadaptor
I've been thinking a lot about what the three most significant trials could be for my practice among the many presented this year at #EuroPCR. In general, I prefer it when the primary endpoint is presented for the first time. This is my selection, feel free to disagree.
#EuroPCR 2023 top picks by @DFCapodanno @EuroInterventio
▶️KISS RCT
🔍SB intervention strategies for #bifurcation #PCI
▶️BIOADAPTOR RCT
🔍DynamX #bioadaptor for #PCI
▶️REFORM RCT
🔍Biolimus-A9 or Paclitaxel #DCB
#CardioTwitter @PCRonline
A team from Elixir will be at the EuroPCR to answer any questions about the latest innovation to treat your CAD patients after the release of the Late Breaking Clinical trial results from Bioadaptor Radomized clinical trial by Dr. Saito!
#bioadaptor #elixirmedical
DynamX Coronary #Bioadaptor System: the first metallic implant that adapts to vessel physiology. Novel uncaging elements in the #implant design allow the bioadaptor to adapt to the #vessel physiology. #cardiotwitter https://t.co/7iVkc2oDno
*CE marked. Not approved in the USA
Dynamx coronary #bioadaptor system: the first metallic implant that adapts to vessel physiology. Novel uncaging elements in the #implant design allow the bioadaptor to adapt to the #vessel physiology. #cardiotwitter
https://t.co/wcSL9xcg2X
*CE marked. Not approved in the USA
Learn more about the DynamX #Bioadaptor, which is designed to restore positive adaptive remodeling: https://t.co/vRt1xsqlkp #beyondDES
#cardotwitter #medtwitter
*CE marked. Not approved in the US
Congratulations Prof. @HolgerNef & team at Universitatsklinikum Giessen for initiating enrollment in Germany in the BIOADAPTOR RCT clinical trial!
For more information about the DynamX Bioadaptor: https://t.co/1dZdW7rJd9
*CE marked. Not approved in the USA
#EuroPCR @PCRonline
Promising #BioAdaptor
My reservation is equating restoration of vasomotion w clinically meaningful endpoints & MACE
Dr. Kereiakes showed new stent, the Dynamx Bioadaptor (Elixir). Has interlocking segments, some of which are bioabsorbed quickly, effectively uncaging the artery. Allows natural vasomotion & possibly reduce long term NIH. N=50. Full session at 16:30, rm 253 w/Leon, Colombo et al
Last Seen Hashtags on Sotwe
Most Popular Users
Elon Musk 
@elonmusk
241M followers
Barack Obama
@barackobama
119.2M followers
Cristiano Ronaldo
@cristiano
112M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.2M followers
KATY PERRY
@katyperry
88.5M followers
Taylor Swift
@taylorswift13
82.3M followers
Lady Gaga
@ladygaga
73.8M followers
Virat Kohli
@imvkohli
71.1M followers
Kim Kardashian
@kimkardashian
70.2M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.3M followers
Neymar Jr
@neymarjr
64M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.8M followers
Selena Gomez
@selenagomez
61.5M followers
X
@x
60.8M followers